Covered recipient · General Payments record
HEATHER R HARRISON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,276.53
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $566.31 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $355.74 | 23 |
| Lilly USA, LLC | $46.85 | 3 |
| Organon LLC | $40.18 | 2 |
| GlaxoSmithKline, LLC. | $32.44 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $23.51 | 1 |
| Janssen Pharmaceuticals, Inc | $20.94 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $18.86 | 1 |
| Novo Nordisk AS | $14.70 | 1 |
| Exeltis, USA Inc. | $13.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.19 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884867 | CMS |
| ABBVIE INC. | $24.59 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884869 | CMS |
| ABBVIE INC. | $13.48 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884871 | CMS |
| ABBVIE INC. | $13.19 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884873 | CMS |
| ABBVIE INC. | $31.38 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884875 | CMS |
| ABBVIE INC. | $3.08 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884877 | CMS |
| ABBVIE INC. | $4.21 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884879 | CMS |
| ABBVIE INC. | $22.19 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884881 | CMS |
| ABBVIE INC. | $27.42 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884883 | CMS |
| ABBVIE INC. | $14.95 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884885 | CMS |
| ABBVIE INC. | $6.18 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884887 | CMS |
| ABBVIE INC. | $31.32 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884889 | CMS |
| ABBVIE INC. | $5.33 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884891 | CMS |
| ABBVIE INC. | $19.16 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884893 | CMS |
| ABBVIE INC. | $4.01 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884895 | CMS |
| ABBVIE INC. | $2.68 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884897 | CMS |
| ABBVIE INC. | $34.75 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884899 | CMS |
| ABBVIE INC. | $15.90 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884901 | CMS |
| ABBVIE INC. | $27.81 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884903 | CMS |
| ABBVIE INC. | $3.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884905 | CMS |
| ABBVIE INC. | $11.30 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884907 | CMS |
| ABBVIE INC. | $6.59 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884909 | CMS |
| ABBVIE INC. | $5.42 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884911 | CMS |
| Boston Scientific Corporation | $18.86 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092664649 | CMS |
| Exeltis, USA Inc. | $13.09 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149994972 | CMS |
| GlaxoSmithKline, LLC. | $15.58 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072705 | CMS |
| GlaxoSmithKline, LLC. | $16.86 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116447024 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $23.51 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146269492 | CMS |
| Janssen Pharmaceuticals, Inc | $20.94 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078220415 | CMS |
| Lilly USA, LLC | $16.52 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135022966 | CMS |
| Lilly USA, LLC | $14.87 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134998572 | CMS |
| Lilly USA, LLC | $15.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134998188 | CMS |
| Novo Nordisk Inc | $14.70 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096810038 | CMS |
| Organon Llc | $21.74 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136203685 | CMS |
| Organon Llc | $18.44 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136203687 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.